Clinical Trials Browser

Phase 2 × Adenocarcinoma × S 1 (combination) × Clear all

NCT06693128 2026-01-28

Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

Phase 2 Active not recruiting

Adenocarcinoma

NCT01552980 2012-03-28

mSOX

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms